메뉴 건너뛰기




Volumn 31, Issue 3, 2003, Pages 968-969

Sepsis: A landscape from the emergency department to the intensive care unit

Author keywords

Emergency department; Landscape; Sepsis

Indexed keywords

C REACTIVE PROTEIN; INFUSION FLUID; INOTROPIC AGENT; PROCALCITONIN;

EID: 0037350230     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000057402.00102.AD     Document Type: Editorial
Times cited : (11)

References (11)
  • 1
    • 0034958947 scopus 로고    scopus 로고
    • Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    • Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
    • (2001) Crit Care Med , vol.29 , pp. 1303-1310
    • Angus, D.C.1    Linde-Zwirble, W.T.2    Lidicker, J.3
  • 2
    • 0031746746 scopus 로고    scopus 로고
    • Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units
    • Lundberg JS, Perl TM, Wiblin T, et al: Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 1998; 26:1020-1024
    • (1998) Crit Care Med , vol.26 , pp. 1020-1024
    • Lundberg, J.S.1    Perl, T.M.2    Wiblin, T.3
  • 3
    • 0035829842 scopus 로고    scopus 로고
    • Early goal-directed therapy in the treatment of severe sepsis and septic shock
    • Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
    • (2001) N Engl J Med , vol.345 , pp. 1368-1377
    • Rivers, E.1    Nguyen, B.2    Havstad, S.3
  • 4
    • 0037351815 scopus 로고    scopus 로고
    • Mortality in Emergency Department Sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule
    • Shapiro NI, Wolfe RE, Moore RB, et al: Mortality in Emergency Department Sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule. Crit Care Med 2003; 31:670-675
    • (2003) Crit Care Med , vol.31 , pp. 670-675
    • Shapiro, N.I.1    Wolfe, R.E.2    Moore, R.B.3
  • 5
    • 0035948519 scopus 로고    scopus 로고
    • National Hospital Ambulatory Medical Care Survey: 1999 Emergency department summary
    • McCaig LF, Burt CW: National Hospital Ambulatory Medical Care Survey: 1999 emergency department summary. Adv Data 2001; 1-36
    • (2001) Adv Data , pp. 1-36
    • McCaig, L.F.1    Burt, C.W.2
  • 6
    • 0033638532 scopus 로고    scopus 로고
    • Critical care in the emergency department: A physiologic assessment and outcome evaluation
    • Nguyen HB, Rivers EP, Havstad S, et al: Critical care in the emergency department: A physiologic assessment and outcome evaluation. Acad Emerg Med 2000; 7:1354-1361
    • (2000) Acad Emerg Med , vol.7 , pp. 1354-1361
    • Nguyen, H.B.1    Rivers, E.P.2    Havstad, S.3
  • 7
    • 0036916441 scopus 로고    scopus 로고
    • Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response
    • Tugrul S, Esen F, Celebi S, et al: Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 2002; 30:747-754
    • (2002) Anaesth Intensive Care , vol.30 , pp. 747-754
    • Tugrul, S.1    Esen, F.2    Celebi, S.3
  • 8
    • 0032807347 scopus 로고    scopus 로고
    • Sublingual capnometry: A new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock
    • Weil MH, Nakagawa Y, Tang W, et al: Sublingual capnometry: A new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 1999; 27:1225-1229
    • (1999) Crit Care Med , vol.27 , pp. 1225-1229
    • Weil, M.H.1    Nakagawa, Y.2    Tang, W.3
  • 9
    • 0035826096 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant human activated protein C for severe sepsis
    • Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
    • (2001) N Engl J Med , vol.344 , pp. 699-709
    • Bernard, G.R.1    Vincent, J.L.2    Laterre, P.F.3
  • 10
    • 0037151571 scopus 로고    scopus 로고
    • Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    • Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
    • (2002) JAMA , vol.288 , pp. 862-871
    • Annane, D.1    Sebille, V.2    Charpentier, C.3
  • 11
    • 0035829852 scopus 로고    scopus 로고
    • Intensive insulin therapy in the critically ill patients
    • van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367
    • (2001) N Engl J Med , vol.345 , pp. 1359-1367
    • Van Den Berghe, G.1    Wouters, P.2    Weekers, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.